DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...
PacBio, developer of advanced sequencing technologies, has announced innovations to its Revio and Vega platforms designed to ...
Alison.ai is launching Creative Genome: an Agentic AI strategist for marketing teams to assist with data-led video generation ...
| Build smarter healthcare apps, faster. See how clinical data repositories help developers unlock clinical data and drive ...
Press Trust of India on MSN
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the ...
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale MENLO PARK ... and preserve PacBio’s hallmark accuracy and data richness. "With lower ...
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph ...
US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...
Dr. Joyce O'Shaughnessy discusses the monarchE trial's findings, emphasizing the importance of abemaciclib in reducing breast cancer recurrence and improving patient access. Joyce O'Shaughnessy, MD, ...
Provides clarity on the aspects to incorporateCompany to address them and resubmit revised protocol MADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN ...
Geographically, EdR Fund Big Data is currently overweight in Europe, where attractive opportunities remain. Technology stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback